Clinical Trial Update: Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of NTX-001 versus standard of care in acute single peripheral nerve injuries; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injuries

Drugs mentioned

• NTX-001

Snippet

Sponsor: Neuraptive Therapeutics Inc. | Conditions: Peripheral Nerve Injuries | Phase 2 | Status: COMPLETED